Table 1.
Allocation of patients according to suPAR below or above median
| Low suPAR < 4.67 ng/mL (N = 40) | High suPAR ≥ 4.67 ng/mL (N = 41) | Low vs high P (Mann-Whitney U test) | |
| suPAR (ng/ml)* | 3,23 (1.22–4.65) | 6.96 (4.67–12.16) | |
| Gender (M/F) | 34/6 | 31/10 | NS |
| Eci-1: | |||
| G/G | 24 | 23 | NS |
| G/A | 4 | 5 | |
| A/A | 0 | 0 | |
| MspA1 l | |||
| A/A | 21 | 16 | NS |
| A/G | 6 | 10 | |
| G/G | 1 | 2 | |
| Age at suPAR meas. (years)* | 28.5 (18.8–42.9) | 34.5 (19.9–78.2) | < 0.001 |
| Time from seroconversion to suPAR meas. (years)* | 0.42 (0.0–4.55) | 0.47 (0.0–5.72) | NS |
| Death within 2 years (Y/N) | 0/40 | 13/28 | < 0.001 |
| Median (range) follow-up (years) from sample to 15th May 1996* | 5.94 (0.21 – 13.63) | 5.38 (0.35 – 10.68) | NS |
| Death before 15th May 1996 (Y/N) | 17/23 | 25/16 | NS |
*Median (range). N = number, M/F = Male/Female, NS = non-significant, Y/N = Yes/No